Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cochlear
Biotech
Sensorion's hearing loss drug reaches target in comeback story
Therapeutic concentrations of Sensorion's hearing loss drug were detected in the inner ears of all sampled patients during a midstage test.
Nick Paul Taylor
Mar 11, 2024 10:35am
Sensorion candidate reduces hearing loss in small midphase trial
Jul 5, 2023 7:53am
Cochlear's Oticon buy faces in-depth antitrust probe in UK
Dec 20, 2022 1:21pm
Cochlear offers up $120M for Demant's hearing implant portfolio
Apr 28, 2022 1:10pm
FDA OKs Cochlear's remote programming tool for hearing implants
Oct 13, 2021 10:15am
New gene-editing technique restores hearing in mice
Jun 4, 2020 10:25am
